Macawadib, Esnairah G.

HRN: 13-01-25  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2026
CEFUROXIME 1.5GM (VIAL)
04/23/2026
04/24/2026
IVTT
1.5g
Q8h
UTI After Pregnancy
Checking Initial Appropriateness 
04/24/2026
CEFUROXIME 500MG (TAB)
04/24/2026
05/01/2026
ORAL
500mg
BID
UTI
Checking Initial Appropriateness 
04/25/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/25/2026
04/25/2026
IV
4.5g
Now Only As Loading Dose
UTI
Checking Initial Appropriateness 
04/25/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/25/2026
05/02/2026
IV
2.25g
Q8hrs
UTI
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: